(Q38993504)

8 September 2017

title

Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting (English)

1 reference

8 September 2017

1 reference

1 reference

Shuangshuang Song

1

1 reference

8 September 2017

Huan Qi

2

1 reference

8 September 2017

Jingwen Xu

3

1 reference

8 September 2017

Pan Guo

4

1 reference

8 September 2017

Fen Chen

5

1 reference

8 September 2017

Fei Li

6

1 reference

8 September 2017

Xinggang Yang

7

1 reference

8 September 2017

Naicheng Sheng

8

1 reference

8 September 2017

Yingliang Wu

9

1 reference

8 September 2017

Weisan Pan

10

1 reference

8 September 2017

publication date

20 May 2014

1 reference

8 September 2017

published in

Pharmaceutical Research

1 reference

8 September 2017

volume

31

1 reference

8 September 2017

issue

11

1 reference

8 September 2017

page(s)

2988-3005

1 reference

A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Somatostatin receptor-mediated tumor-targeting drug delivery using octreotide-PEG-deoxycholic acid conjugate-modified N-deoxycholic acid-O, N-hydroxyethylation chitosan micelles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Advances in polymeric micelles for drug delivery and tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Multifunctional drug delivery system for targeting tumor and its acidic microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

A pH-sensitive gene delivery system based on folic acid-PEG-chitosan - PAMAM-plasmid DNA complexes for cancer cell targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Targeting by cmHsp70.1-antibody coated and survivin miRNA plasmid loaded nanoparticles to radiosensitize glioblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Biodegradable polymeric nanoparticles based drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Hyaluronan: a multifunctional, megaDalton, stealth molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Biological effects of hyaluronan in connective tissues, eye, skin, venous wall. Role in aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Hyaluronan synthase-3 is upregulated in metastatic colon carcinoma cells and manipulation of expression alters matrix retention and cellular growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

CD44: from adhesion molecules to signalling regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Hyaluronidases: their genomics, structures, and mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Hyaluronan catabolism: a new metabolic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Hyaluronan: from extracellular glue to pericellular cue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Hyaluronan-CD44 Interaction Promotes c-Src-mediated Twist Signaling, MicroRNA-10b Expression, and RhoA/RhoC Up-regulation, Leading to Rho-kinase-associated Cytoskeleton Activation and Breast Tumor Cell Invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

A hyaluronan synthase suppressor, 4-methylumbelliferone, inhibits liver metastasis of melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Inhibition of tumor growth in vivo by hyaluronan oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

High interstitial fluid pressure - an obstacle in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Development of hyaluronic acid-Fe2O3 hybrid magnetic nanoparticles for targeted delivery of peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl L-glutamate)-b-hyaluronan polymersomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Simple primary structure, complex turnover regulation and multiple roles of hyaluronan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Hyaluronan fragments: an information-rich system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Structure of human hyaluronidase-1, a hyaluronan hydrolyzing enzyme involved in tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Hyaluronan: its nature, distribution, functions and turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Fast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo forster resonance energy transfer imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Hyaluronic acid (HA) presentation as a tool to modulate and control the receptor-mediated uptake of HA-coated nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

The CD44/integrins interplay and the significance of receptor binding and re-presentation in the uptake of RGD-functionalized hyaluronic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1393-4

Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel

21 January 2018

1 reference

12 December 2020

Effect of poly(N-vinyl-pyrrolidone)-block-poly(D,L-lactide) as coating agent on the opsonization, phagocytosis, and pharmacokinetics of biodegradable nanoparticles

1 reference

12 December 2020

1 reference

12 December 2020

Hyaluronate-covered nanoparticles for the therapeutic targeting of cartilage

1 reference

12 December 2020

Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent

1 reference

12 December 2020

Internalization of the hyaluronan receptor CD44 by chondrocytes

1 reference

12 December 2020

10.1007/S11095-014-1393-4

Identifiers

DOI

1 reference

8 September 2017

1 reference